Patent Yard Sign in
Expired Canadian patentCanada

Process for the manufacture of novel tri-substituted imidazole derivatives

CA 1185976 A · Owner: Novartis Pharma Canada Inc./Novartis Pharma Canada Inc. · Inventors: Sallmann, Alfred

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

This invention relates to novel tri-substituted imidazole derivatives of the general formula I, in which R1 and R2 represent independently either optionally substituted phenyl, or one of R1 and R2, represents an optionally substituted pyrrolyl furyl, thienyl, pyridyl or 1-oxopyridyl group; A represents a straight chain or cyclic lower alkyl group which may be unsaturated; and R3 represents a carboxy group or substituted carboxy group such as an ester or carbamoyl group with the proviso that if (i) A represents methylene or ethylidene and R3 represents, eth? carbamoyl then one of R1 and R2 is other than phenyl and (ii) if A, represents ethylidene and R3 represents carboxy or carbamoyl then …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted April 23, 1985. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended April 23, 2002.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 23, 1981
GrantedApril 23, 1985
Term endedApril 23, 2002
Patent numberCA 1185976 A
Classification (IPC)C07D233/64 +2 more

Timeline

Timeline From CIPO dates

1982198519881991199419972000Application filedJuly 23, 1981Patent grantedApril 23, 1985Term endedApril 23, 2002

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.